GenomeNet

Database: UniProt
Entry: P12643
LinkDB: P12643
Original site: P12643 
ID   BMP2_HUMAN              Reviewed;         396 AA.
AC   P12643;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1989, sequence version 1.
DT   01-MAY-2013, entry version 157.
DE   RecName: Full=Bone morphogenetic protein 2;
DE            Short=BMP-2;
DE   AltName: Full=Bone morphogenetic protein 2A;
DE            Short=BMP-2A;
DE   Flags: Precursor;
GN   Name=BMP2; Synonyms=BMP2A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3201241; DOI=10.1126/science.3201241;
RA   Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J.,
RA   Kriz R.W., Hewick R.M., Wang E.A.;
RT   "Novel regulators of bone formation: molecular clones and
RT   activities.";
RL   Science 242:1528-1534(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Shore E.M., Xu M.-Q., Calvert G., Moriatis J., Kaplan F.S.;
RT   "Human bone morphogenetic protein 2 (BMP-2) genomic DNA sequence.";
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [4]
RP   INTERACTION WITH SOSTDC1.
RX   PubMed=15020244; DOI=10.1016/j.bbrc.2004.02.075;
RA   Yanagita M., Oka M., Watabe T., Iguchi H., Niida A., Takahashi S.,
RA   Akiyama T., Miyazono K., Yanagisawa M., Sakurai T.;
RT   "USAG-1: a bone morphogenetic protein antagonist abundantly expressed
RT   in the kidney.";
RL   Biochem. Biophys. Res. Commun. 316:490-500(2004).
RN   [5]
RP   PROTEOLYTIC PROCESSING, AND PROPEPTIDE.
RX   PubMed=20555025; DOI=10.1210/en.2010-0326;
RA   Heng S., Paule S., Hardman B., Li Y., Singh H., Rainczuk A.,
RA   Stephens A.N., Nie G.;
RT   "Posttranslational activation of bone morphogenetic protein 2 is
RT   mediated by proprotein convertase 6 during decidualization for
RT   pregnancy establishment.";
RL   Endocrinology 151:3909-3917(2010).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 292-396.
RX   PubMed=10074410; DOI=10.1006/jmbi.1999.2590;
RA   Scheufler C., Sebald W., Huelsmeyer M.;
RT   "Crystal structure of human bone morphogenetic protein-2 at 2.7 A
RT   resolution.";
RL   J. Mol. Biol. 287:103-115(1999).
CC   -!- FUNCTION: Induces cartilage and bone formation.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. Interacts with SOSTDC1.
CC       Interacts with GREM2, RGMA, RGMB and RGMC. Interacts with ASPN (By
CC       similarity).
CC   -!- INTERACTION:
CC       P36894:BMPR1A; NbExp=2; IntAct=EBI-1029262, EBI-1029237;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Particularly abundant in lung, spleen and
CC       colon and in low but significant levels in heart, brain, placenta,
CC       liver, skeletal muscle, kidney, pancreas, prostate, ovary and
CC       small intestine.
CC   -!- PHARMACEUTICAL: Available under the name Infuse (Medtronic Sofamor
CC       Danek). Used for treating open tibial shaft fractures.
CC   -!- SIMILARITY: Belongs to the TGF-beta family.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Bone morphogenetic protein 2
CC       entry;
CC       URL="http://en.wikipedia.org/wiki/Bone_morphogenetic_protein_2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M22489; AAA51834.1; -; mRNA.
DR   EMBL; AF040249; AAF21646.1; -; Genomic_DNA.
DR   EMBL; AL035668; CAB82007.1; -; Genomic_DNA.
DR   IPI; IPI00025069; -.
DR   PIR; B37278; BMHU2.
DR   RefSeq; NP_001191.1; NM_001200.2.
DR   UniGene; Hs.73853; -.
DR   PDB; 1ES7; X-ray; 2.90 A; A/C=283-396.
DR   PDB; 1REU; X-ray; 2.65 A; A=294-396.
DR   PDB; 1REW; X-ray; 1.86 A; A/B=283-396.
DR   PDB; 2GOO; X-ray; 2.20 A; A/D=283-396.
DR   PDB; 2H62; X-ray; 1.85 A; A/B=283-396.
DR   PDB; 2H64; X-ray; 1.92 A; A=283-396.
DR   PDB; 2QJ9; X-ray; 2.44 A; A/B=283-396.
DR   PDB; 2QJA; X-ray; 2.60 A; A/B=283-396.
DR   PDB; 2QJB; X-ray; 2.50 A; A/B=283-396.
DR   PDB; 3BK3; X-ray; 2.70 A; A/B=283-396.
DR   PDB; 3BMP; X-ray; 2.70 A; A=283-396.
DR   PDBsum; 1ES7; -.
DR   PDBsum; 1REU; -.
DR   PDBsum; 1REW; -.
DR   PDBsum; 2GOO; -.
DR   PDBsum; 2H62; -.
DR   PDBsum; 2H64; -.
DR   PDBsum; 2QJ9; -.
DR   PDBsum; 2QJA; -.
DR   PDBsum; 2QJB; -.
DR   PDBsum; 3BK3; -.
DR   PDBsum; 3BMP; -.
DR   ProteinModelPortal; P12643; -.
DR   DIP; DIP-5792N; -.
DR   IntAct; P12643; 1.
DR   MINT; MINT-6772716; -.
DR   STRING; 9606.ENSP00000368104; -.
DR   PhosphoSite; P12643; -.
DR   DMDM; 115068; -.
DR   PaxDb; P12643; -.
DR   PRIDE; P12643; -.
DR   DNASU; 650; -.
DR   Ensembl; ENST00000378827; ENSP00000368104; ENSG00000125845.
DR   GeneID; 650; -.
DR   KEGG; hsa:650; -.
DR   UCSC; uc002wmu.1; human.
DR   CTD; 650; -.
DR   GeneCards; GC20P006696; -.
DR   HGNC; HGNC:1069; BMP2.
DR   MIM; 112261; gene.
DR   neXtProt; NX_P12643; -.
DR   Orphanet; 261295; 20p12.3 microdeletion syndrome.
DR   Orphanet; 93396; Brachydactyly type A2.
DR   Orphanet; 907; Wolff-Parkinson-White syndrome.
DR   PharmGKB; PA25379; -.
DR   eggNOG; NOG243555; -.
DR   HOGENOM; HOG000249478; -.
DR   HOVERGEN; HBG004860; -.
DR   InParanoid; P12643; -.
DR   KO; K04662; -.
DR   OMA; DEHSWSQ; -.
DR   OrthoDB; EOG4C2H9R; -.
DR   PhylomeDB; P12643; -.
DR   Pathway_Interaction_DB; bmppathway; BMP receptor signaling.
DR   Reactome; REACT_111102; Signal Transduction.
DR   Reactome; REACT_118779; Extracellular matrix organization.
DR   ChEMBL; CHEMBL1926496; -.
DR   DrugBank; DB00641; Simvastatin.
DR   EvolutionaryTrace; P12643; -.
DR   GenomeRNAi; 650; -.
DR   NextBio; 2640; -.
DR   ArrayExpress; P12643; -.
DR   Bgee; P12643; -.
DR   CleanEx; HS_BMP2; -.
DR   Genevestigator; P12643; -.
DR   GermOnline; ENSG00000125845; Homo sapiens.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
DR   GO; GO:0070700; F:BMP receptor binding; IDA:MGI.
DR   GO; GO:0019211; F:phosphatase activator activity; IDA:MGI.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:MGI.
DR   GO; GO:0004745; F:retinol dehydrogenase activity; ISS:UniProtKB.
DR   GO; GO:0046332; F:SMAD binding; IDA:BHF-UCL.
DR   GO; GO:0003181; P:atrioventricular valve morphogenesis; ISS:UniProtKB.
DR   GO; GO:0003130; P:BMP signaling pathway involved in heart induction; IDA:BHF-UCL.
DR   GO; GO:0035630; P:bone mineralization involved in bone maturation; IDA:BHF-UCL.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; ISS:UniProtKB.
DR   GO; GO:0060317; P:cardiac epithelial to mesenchymal transition; IDA:BHF-UCL.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; IMP:BHF-UCL.
DR   GO; GO:0055008; P:cardiac muscle tissue morphogenesis; ISS:UniProtKB.
DR   GO; GO:0051216; P:cartilage development; IEA:UniProtKB-KW.
DR   GO; GO:0071773; P:cellular response to BMP stimulus; IDA:BHF-UCL.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Compara.
DR   GO; GO:0060128; P:corticotropin hormone secreting cell differentiation; ISS:UniProtKB.
DR   GO; GO:0035054; P:embryonic heart tube anterior/posterior pattern specification; ISS:UniProtKB.
DR   GO; GO:0003203; P:endocardial cushion morphogenesis; ISS:UniProtKB.
DR   GO; GO:0040007; P:growth; IEA:InterPro.
DR   GO; GO:0001701; P:in utero embryonic development; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; ISS:UniProtKB.
DR   GO; GO:0048839; P:inner ear development; ISS:UniProtKB.
DR   GO; GO:0072138; P:mesenchymal cell proliferation involved in ureteric bud development; ISS:UniProtKB.
DR   GO; GO:0032348; P:negative regulation of aldosterone biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:2000726; P:negative regulation of cardiac muscle cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IDA:HGNC.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:BHF-UCL.
DR   GO; GO:2000065; P:negative regulation of cortisol biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0043569; P:negative regulation of insulin-like growth factor receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0003308; P:negative regulation of Wnt receptor signaling pathway involved in heart development; IDA:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; ISS:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; IDA:MGI.
DR   GO; GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0060039; P:pericardium development; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:MGI.
DR   GO; GO:0048711; P:positive regulation of astrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IDA:BHF-UCL.
DR   GO; GO:0061036; P:positive regulation of cartilage development; IDA:MGI.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IDA:UniProtKB.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IDA:BHF-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:BHF-UCL.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0042482; P:positive regulation of odontogenesis; ISS:UniProtKB.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IDA:BHF-UCL.
DR   GO; GO:0033690; P:positive regulation of osteoblast proliferation; ISS:UniProtKB.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted SMAD protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0010922; P:positive regulation of phosphatase activity; IDA:MGI.
DR   GO; GO:1901522; P:positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus; IDA:BHF-UCL.
DR   GO; GO:0060804; P:positive regulation of Wnt receptor signaling pathway by BMP signaling pathway; ISS:UniProtKB.
DR   GO; GO:0031648; P:protein destabilization; IEA:Compara.
DR   GO; GO:0006029; P:proteoglycan metabolic process; IEA:Compara.
DR   GO; GO:0042487; P:regulation of odontogenesis of dentin-containing tooth; IEA:Compara.
DR   GO; GO:0001666; P:response to hypoxia; ISS:UniProtKB.
DR   GO; GO:0060395; P:SMAD protein signal transduction; IDA:UniProtKB.
DR   GO; GO:0021978; P:telencephalon regionalization; ISS:UniProtKB.
DR   GO; GO:0060129; P:thyroid-stimulating hormone-secreting cell differentiation; ISS:UniProtKB.
DR   InterPro; IPR002405; Inhibin_asu.
DR   InterPro; IPR001839; TGF-b_C.
DR   InterPro; IPR001111; TGF-b_N.
DR   InterPro; IPR015615; TGF-beta-rel.
DR   InterPro; IPR017948; TGFb_CS.
DR   PANTHER; PTHR11848; PTHR11848; 1.
DR   Pfam; PF00019; TGF_beta; 1.
DR   Pfam; PF00688; TGFb_propeptide; 1.
DR   PRINTS; PR00669; INHIBINA.
DR   SMART; SM00204; TGFB; 1.
DR   PROSITE; PS00250; TGF_BETA_1; 1.
DR   PROSITE; PS51362; TGF_BETA_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chondrogenesis; Cleavage on pair of basic residues;
KW   Complete proteome; Cytokine; Developmental protein; Differentiation;
KW   Disulfide bond; Glycoprotein; Growth factor; Osteogenesis;
KW   Pharmaceutical; Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     23       Potential.
FT   PROPEP       24    282       Cleaved by PCSK5.
FT                                /FTId=PRO_0000033824.
FT   CHAIN       283    396       Bone morphogenetic protein 2.
FT                                /FTId=PRO_0000033825.
FT   CARBOHYD    135    135       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    163    163       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    164    164       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    200    200       N-linked (GlcNAc...) (Potential).
FT   DISULFID    296    361
FT   DISULFID    325    393
FT   DISULFID    329    395
FT   DISULFID    360    360       Interchain.
FT   VARIANT      37     37       S -> A (in dbSNP:rs2273073).
FT                                /FTId=VAR_020061.
FT   VARIANT      77     77       P -> S (in dbSNP:rs36105541).
FT                                /FTId=VAR_052568.
FT   VARIANT     106    106       A -> T (in dbSNP:rs2273074).
FT                                /FTId=VAR_020062.
FT   VARIANT     161    161       L -> S (in dbSNP:rs34183594).
FT                                /FTId=VAR_052569.
FT   VARIANT     190    190       R -> S (in dbSNP:rs235768).
FT                                /FTId=VAR_024232.
FT   VARIANT     387    387       D -> G (in dbSNP:rs11545591).
FT                                /FTId=VAR_052570.
FT   STRAND      295    299
FT   STRAND      302    304
FT   HELIX       305    308
FT   TURN        311    313
FT   STRAND      314    316
FT   STRAND      318    321
FT   STRAND      324    326
FT   STRAND      337    339
FT   HELIX       341    352
FT   STRAND      354    356
FT   STRAND      360    374
FT   STRAND      380    396
SQ   SEQUENCE   396 AA;  44702 MW;  20653A3987B25E60 CRC64;
     MVAGTRCLLA LLLPQVLLGG AAGLVPELGR RKFAAASSGR PSSQPSDEVL SEFELRLLSM
     FGLKQRPTPS RDAVVPPYML DLYRRHSGQP GSPAPDHRLE RAASRANTVR SFHHEESLEE
     LPETSGKTTR RFFFNLSSIP TEEFITSAEL QVFREQMQDA LGNNSSFHHR INIYEIIKPA
     TANSKFPVTR LLDTRLVNQN ASRWESFDVT PAVMRWTAQG HANHGFVVEV AHLEEKQGVS
     KRHVRISRSL HQDEHSWSQI RPLLVTFGHD GKGHPLHKRE KRQAKHKQRK RLKSSCKRHP
     LYVDFSDVGW NDWIVAPPGY HAFYCHGECP FPLADHLNST NHAIVQTLVN SVNSKIPKAC
     CVPTELSAIS MLYLDENEKV VLKNYQDMVV EGCGCR
//
DBGET integrated database retrieval system